TriSalus Life Sciences, Inc. Common Stock (TLSI) is a publicly traded Healthcare sector company. As of October 21, 2026, TLSI trades at $3.67 with a market cap of $217.36M and a P/E ratio of -3.31. TLSI moved +3.82% today. Year to date, TLSI is -40.00%; over the trailing twelve months it is -30.68%. Its 52-week range spans $2.20 to $7.95. Analyst consensus is strong buy with an average price target of $10.40. Rallies surfaces TLSI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks TLSI insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $3.67 |
| Market Cap | $217.36M |
| P/E Ratio | -3.31 |
| EPS | $-1.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.95 |
| 52-Week Low | $2.20 |
| Volume | 77.35K |
| Avg Volume | 0 |
| Revenue (TTM) | $45.08M |
| Net Income | $-28.21M |
| Gross Margin | 85.79% |
5 analysts cover TLSI: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.40.